BioSpace News Archive

Chugai to Commercialize Foundation Medicine’s Suite of Comprehensive Genomic Profiling (CGP) Services in Japan, Expanding Patient Access to Personalized Cancer Care

New site will support complex clinical research and bring more than 200 new jobs to community.

Levocetirizine Dihydrochloride Tablets USP, 5 mg is an over-the-counter antihistamine used for 24-hour relief of allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing.

LifeScan, Inc. is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion.

Combining germline and somatic information provides more comprehensive view from diagnosis through treatment.

ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, announced today that the ReShape vBloc™ product will be discussed during the Bariatric Metabolic Surgery Standardization World Consensus Meeting taking place in New Delhi, India from March 22-24, 2018.

Dr. James Chen, the Chief Executive Officer of Origin Agritech Limited (NASDAQ: SEED) (“the Company” or “Origin”), an agricultural biotechnology trait and corn seed technology provider, presented the Company’s strategy for SEED+ Rural E-Commerce with Blockchain Technologies

OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing intratumoral cancer immunotherapies, today announced that Daniel J. O’Connor, Chief Executive Officer of OncoSec, will present at the Oppenheimer 28th Annual Healthcare Conference being held March 20-21, 2018 at the Westin New York Grand Central in New York City.

First and only subcutaneous immunoglobulin (SCIg) approved for the treatment of CIDP based on the largest controlled clinical study in CIDP

Chip Draper to serve as Senior Vice President of Worldwide Sales & Marketing leading global commercial initiatives